-transparent.png){kind=logo}
A group of 88 seronegative 11-year-old Dutch girls was selected to be tested for human leukocyte antigens (HLA) and for both the in vivo and in vitro immune response to rubella virus, 6 and 12 weeks after rubella vaccination. Although a slight influence of HLA-associated factors on the antibody levels, as measured by the enzyme-linked immunosorbent assay could not be excluded, no evidence for HLA-associated control of the rubella-specific immune response following vaccination was obtained. From these data it is concluded that HLA-associated factors cannot be expected to hamper the effectiveness of large-scale rubella vaccination procedures.
Related Publications
W Van Eden, and
F UytdeHaag, and
H G Loggen, and
A D Plantinga, and
R R De Vries, and
J J Van Rood
August 1974,
Clinical and experimental immunology,
W Van Eden, and
F UytdeHaag, and
H G Loggen, and
A D Plantinga, and
R R De Vries, and
J J Van Rood
February 1982,
Tissue antigens,
W Van Eden, and
F UytdeHaag, and
H G Loggen, and
A D Plantinga, and
R R De Vries, and
J J Van Rood
January 1988,
Quaderni Sclavo di diagnostica clinica e di laboratorio,
W Van Eden, and
F UytdeHaag, and
H G Loggen, and
A D Plantinga, and
R R De Vries, and
J J Van Rood
December 2004,
Human immunology,
W Van Eden, and
F UytdeHaag, and
H G Loggen, and
A D Plantinga, and
R R De Vries, and
J J Van Rood
July 2014,
Vaccine,
W Van Eden, and
F UytdeHaag, and
H G Loggen, and
A D Plantinga, and
R R De Vries, and
J J Van Rood
May 1982,
Infection and immunity,
W Van Eden, and
F UytdeHaag, and
H G Loggen, and
A D Plantinga, and
R R De Vries, and
J J Van Rood
April 1980,
Japanese journal of medical science & biology,
W Van Eden, and
F UytdeHaag, and
H G Loggen, and
A D Plantinga, and
R R De Vries, and
J J Van Rood
December 1979,
The Journal of hygiene,
W Van Eden, and
F UytdeHaag, and
H G Loggen, and
A D Plantinga, and
R R De Vries, and
J J Van Rood
December 2020,
Vaccine,
W Van Eden, and
F UytdeHaag, and
H G Loggen, and
A D Plantinga, and
R R De Vries, and
J J Van Rood
May 2007,
Clinical and vaccine immunology : CVI,
